Indication
Peritoneal Carcinoma
1 clinical trial
1 product
Clinical trial
Phase I Study of Specific CAR-T Dual-targeting HER2 and PD-L1 in Patients With Pleural or Peritoneal Metastasis of HER2 Positive CancerStatus: Recruiting, Estimated PCD: 2024-12-30